Ipamorelin Product Information
Ipamorelin is a synthetic growth hormone–releasing peptide (GHRP) supplied as a high-purity lyophilized compound intended exclusively for laboratory research use by qualified professionals. Manufactured under controlled conditions to ensure molecular consistency, analytical reliability, and stability. For laboratory research use only. Available concentrations:10 mg Technical Classification Peptide Type: Synthetic growth hormone–releasing peptide (GHRP) Peptide Class: Ghrelin receptor (GHS-R1a) agonist analog Amino Acid Length: Pentapeptide Structural Type: Linear peptide Source: Synthetic (laboratory-produced) Physical Form: Lyophilized powder Purity: >99% (HPLC) Research Context Ipamorelin is utilized in preclinical and experimental research settings investigating: Growth hormone secretagogue receptor (GHS-R1a) signaling Pulsatile growth hormone release mechanisms Hypothalamic–pituitary axis regulation Peptide-receptor binding selectivity and signaling specificity Comparative analysis of GHRP family peptides Endocrine feedback loop modeling in experimental systems Ipamorelin has been studied in in vitro and animal models for its role in selective GH-related signaling with minimal off-target endocrine activity compared to earlier GHRP analogs. Research applications focus on mechanistic pathway exploration and receptor-level analysis, not therapeutic use. Handling & Storage Storage Conditions: 2–8 °C, protected from light Stability: Lyophilized format supports extended stability when stored under recommended conditions Reconstitution: For laboratory research protocols only, using appropriate sterile laboratory techniques
